Thomas Kowalski

Bochum, NW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 22 publications

Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with lomustine/temozolomide.

Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with lomustine/temozolomide.

Journal: Neuro-oncology

Published: October 01, 2024

Pharmacological treatment of depression in patients with brain tumors.

Pharmacological treatment of depression in patients with brain tumors.

Journal: International journal of cancer

Published: December 05, 2023

Social cognition and occupational reintegration in primary central nervous system lymphoma long-term survivors: a secondary analysis of a combined data set.

Social cognition and occupational reintegration in primary central nervous system lymphoma long-term survivors: a secondary analysis of a combined data set.

Journal: Journal of psychosocial oncology

Published: November 20, 2023

Rational treatment of depressive syndromes in brain tumor patients

Rational treatment of depressive syndromes in brain tumor patients

Journal: Der Nervenarzt

Published: September 14, 2023

Survival, prognostic factors, hospitalization time and clinical performance status after first cerebral relapse or progression in 54 patients with primary CNS lymphoma not eligible for high dose chemotherapy: a retrospective analysis.

Survival, prognostic factors, hospitalization time and clinical performance status after first cerebral relapse or progression in 54 patients with primary CNS lymphoma not eligible for high dose chemotherapy: a retrospective analysis.

Journal: Neurological research and practice

Published: January 08, 2023

Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial.

Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trial.

Journal: Journal of neuro-oncology

Published: November 09, 2022

Outcome and prognostic factors of very old patients with primary CNS lymphoma: a retrospective analysis of patients ≥80 years treated with high-dose methotrexate-based chemotherapy.

Outcome and prognostic factors of very old patients with primary CNS lymphoma: a retrospective analysis of patients ≥80 years treated with high-dose methotrexate-based chemotherapy.

Journal: Leukemia & lymphoma

Published: July 20, 2022

Pre- and postoperative self-reported and objectively assessed neurocognitive functioning in lower grade glioma patients.

Pre- and postoperative self-reported and objectively assessed neurocognitive functioning in lower grade glioma patients.

Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia

Published: July 13, 2022

High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Primary CNS Lymphoma: A Retrospective Monocentric Analysis of Long-Term Outcome, Prognostic Factors, and Toxicity.

High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Primary CNS Lymphoma: A Retrospective Monocentric Analysis of Long-Term Outcome, Prognostic Factors, and Toxicity.

Journal: Cancers

Published: April 01, 2022

Patients with Primary Central Nervous System Lymphoma Not Eligible for Clinical Trials: Prognostic Factors, Treatment and Outcome.

Patients with Primary Central Nervous System Lymphoma Not Eligible for Clinical Trials: Prognostic Factors, Treatment and Outcome.

Journal: Cancers

Published: June 02, 2021

The value of bone marrow biopsy for staging of patients with primary CNS lymphoma.

The value of bone marrow biopsy for staging of patients with primary CNS lymphoma.

Journal: Neuro-oncology

Published: May 13, 2021

Mental time travel in patients "cured" from primary central nervous system lymphoma.

Mental time travel in patients "cured" from primary central nervous system lymphoma.

Journal: Journal of clinical and experimental neuropsychology

Published: April 21, 2021

Showing 1-12 of 22

Last Updated: 09/26/2026